EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study

Evgeny Pokushalov iD, Andrey Ponomarenko iD, John Smith, Michael Johnson, Claire Garcia, Inessa Pak, Evgenya Shrainer iD, Dmitry Kudlay iD, Sevda Bayramova, Richard Miller

Nutrients · 2024

DOI: 10.3390/nu16132023 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Evgeny Pokushalov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for New Medical Technologies, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Dietary Supplements, Cholesterol, LDL. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Center for New Medical Technologies, Novosibirsk, Russia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence suggests that personalized dietary supplement regimens can significantly influence lipid metabolism and cardiovascular risk. The efficacy of AI-guided dietary supplement prescriptions, compared with standard physician-guided prescriptions, remains underexplored. In a randomized, parallel-group pilot study, 70 patients aged 40–75 years with LDL-C levels between 70 and 190 mg/dL were enrolled. Participants were randomized to receive either AI-guided dietary supplement prescriptions or standard physician-guided prescriptions for 90 days. The primary endpoint was the percent change in LDL-C levels. Secondary endpoints included changes in total cholesterol, HDL-C, triglycerides, and hsCRP. Supplement adherence and side effects were monitored. Sixty-seven participants completed the study. The AI-guided group experienced a 25.3% reduction in LDL-C levels (95% CI: −28.7% to −21.9%), significantly greater than the 15.2% reduction in the physician-guided group (95% CI: −18.5% to −11.9%; p < 0.01). Total cholesterol decreased by 15.4% (95% CI: −19.1% to −11.7%) in the AI-guided group compared with 8.1% (95% CI: −11.5% to −4.7%) in the physician-guided group (p < 0.05). Triglycerides were reduced by 22.1% (95% CI: −27.2% to −17.0%) in the AI-guided group versus 12.3% (95% CI: −16.7% to −7.9%) in the physician-guided group (p < 0.01). HDL-C and hsCRP changes were not significantly different between groups. The AI-guided group received a broader variety of supplements, including plant sterols, omega-3 fatty acids, red yeast rice, coenzyme Q10, niacin, and fiber supplements. Side effects were minimal and comparable between groups. AI-guided dietary supplement prescriptions significantly reduce LDL-C and triglycerides more effectively than standard physician-guided prescriptions, highlighting the potential for AI-driven personalization in managing hypercholesterolemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dietary SupplementsCholesterol, LDLHumansMiddle AgedPilot ProjectsMaleFemaleAgedAdultHypercholesterolemiaTriglyceridesTreatment OutcomeCholesterol, HDL

Stichwörter der Autor:innen

AI-guided prescriptionsLDL-Ccardiovascular healthdietary supplementspersonalized medicinetriglycerides

Substanzen

Cholesterol, LDLTriglyceridesCholesterol, HDL

Autor:innen und Institutionen

  • Center for New Medical Technologies, 630090 Novosibirsk, Russia.
  • Scientific Research Laboratory, Triangel Scientific, San Francisco, CA 94101, USA.
  • Institute of Pharmacy, I.M. Sechenov First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia.

ORCID-Profile: Evgeny Pokushalov, Andrey Ponomarenko, Evgenya Shrainer, Dmitry Kudlay

Förderung

  • Center for New Medical Technologies, Novosibirsk, Russia

Zitieren

APA

Pokushalov, E., Ponomarenko, A., Smith, J., Johnson, M., Garcia, C., Pak, I., Shrainer, E., Kudlay, D., Bayramova, S., & Miller, R. (2024). Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study. Nutrients. https://doi.org/10.3390/nu16132023

Vancouver

Pokushalov E, Ponomarenko A, Smith J, Johnson M, Garcia C, Pak I, et al. Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study. Nutrients. 2024. doi:10.3390/nu16132023

BibTeX
@article{Pokushalov2024,
  author = {Pokushalov, Evgeny and Ponomarenko, Andrey and Smith, John and Johnson, Michael and Garcia, Claire and Pak, Inessa and Shrainer, Evgenya and Kudlay, Dmitry and Bayramova, Sevda and Miller, Richard},
  title = {Efficacy of AI-Guided (GenAISTM) Dietary Supplement Prescriptions versus Traditional Methods for Lowering LDL Cholesterol: A Randomized Parallel-Group Pilot Study},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16132023}
}
Kostenlos starten →